SCHEMBL7366565

SCHEMBL7366565

O=C(NCc1ccncc1)c1cccnc1Oc1cccnc1

nearest known ligand 0.73

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 2/20 0.73
HPGD P15428 2/20 0.55
LMNA P02545 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
ALDH1A1 P00352 1/20 0.54
MAPK1 P28482 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7369138 0.92 MAPK8 (0.69) MAPK8HPGDLMNASMN1; SMN2ALDH1A1
SCHEMBL7364353 0.91 HPGD (0.68) MAPK8HPGDLMNASMN1; SMN2
SCHEMBL7370313 0.91 MAPK8 (0.67) MAPK8
SCHEMBL7364091 0.90 HPGD (0.71) MAPK8HPGDLMNASMN1; SMN2
SCHEMBL7370259 0.88 MAPK8 (0.64) MAPK8HPGDLMNASMN1; SMN2
SCHEMBL7368824 0.88 MAPK8 (0.64) MAPK8HPGDLMNASMN1; SMN2
SCHEMBL7369122 0.87 MAPK8 (0.62) MAPK8HPGDLMNASMN1; SMN2
SCHEMBL7365200 0.87 MAPK8 (0.62) MAPK8HPGDLMNASMN1; SMN2ALDH1A1
SCHEMBL7369871 0.86 MAPK8 (0.61) MAPK8HPGDLMNASMN1; SMN2
SCHEMBL7366808 0.86 MAPK8 (0.61) MAPK8HPGDLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380218-B1 FOR THERAPY OF RESPIRATORY, ALLERGIC, AND INFLAMMATORY DISORDERS COMPRISING ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ACUTE RESPIRATORY DISEASE SYNDROME, PULMONARY HYPERSENSITIVITY, AND ALLERGIC RHINITIS IN A MAMMAL PFIZER INC 2002-04-30 US disclosed
EP-0971894-A1 NICOTINAMIDE DERIVATIVES Pfizer Products Inc. (US) 2000-01-19 EP disclosed
WO-1998045268-A1 NICOTINAMIDE DERIVATIVES PFIZER PRODUCTS INC. (US) 1998-10-15 WO disclosed